A large-scale retrospective clinical study (8) involving 3,060 patients with various malignancies (including breast cancer) demonstrated a significant association between serum creatinine to cystatin C ratio and survival outcomes in cancer patients. The gene discussed is CST3; the disease is breast carcinoma.